The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.
 
Seth P. Lerner
Stock and Other Ownership Interests - C2i genomics
Honoraria - Annenberg Center for Health Sciences at Eisenhower (ACHS); Clinical Care Options; Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; C2i Genomics; Ferring; Pfizer/EMD Serono; Protara Therapeutics; Stimit; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; Urogen pharma; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate
 
Catherine Tangen
No Relationships to Disclose
 
Robert S. Svatek
Consulting or Advisory Role - CG Oncology; UroGen pharma; Verity Pharmaceuticals
Research Funding - JBL; Merck; Pacific Edge Biotechnology
Travel, Accommodations, Expenses - Pacific Edge Biotechnology
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Olympus; pacific edge; Photocure; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Kamal S. Pohar
Honoraria - Photocure
 
Eila C. Skinner
Research Funding - Genentech/Roche
 
Anne K. Schuckman
Honoraria - pacific edge; Photocure
Consulting or Advisory Role - Fergene; Gerson Lehrman Group; Pacific Edge Biotechnology; Pacific Edge Biotechnology; Photocure
Speakers' Bureau - Photocure
 
Arthur I. Sagalowsky
No Relationships to Disclose
 
Norm D. Smith
Employment - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
Other Relationship - Caris Life Sciences
 
Ashish M. Kamat
Honoraria - AstraZeneca (I); Tesaro (I)
Consulting or Advisory Role - Asieris Pharmaceuticals; Astellas Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Eisai; EnGeneIC; FerGene; Imagin Medical; Incyte; Janssen; Medac; Merck; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; TMC Innovation; Urogen pharma; US Biotest
Research Funding - Adolor; Bristol-Myers Squibb; FKD Therapies; Heat Biologics; Janssen/Taris; Merck; NIH; Patient-Centered Outcomes Research Institute (PCORI); Photocure; Seagen; SWOG; Taris BioMedical; The Leo & Anne Albert Institute for Bladder Cancer Care and Research (AIBCCR)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; International Bladder Cancer Group (IBCG); International Bladder Cancer Network; Journal of Urology; UroToday
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Pfizer/EMD Serono; Roche; Seagen; Sesen Bio
Research Funding - Sesen Bio (Inst)
 
Melissa Plets
No Relationships to Disclose
 
Rick Bangs
Consulting or Advisory Role - Nonagen Bioscience
Other Relationship - ASCO; Bladder Cancer Advocacy Network; Facing our Risk of Cancer Empowered; Facing our Risk of Cancer Empowered; Institute for Clinical and Economic Review; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Comprehensive Cancer Network; SWOG; SWOG; SWOG; University of Puerto Rico
 
Theresa M. Koppie
Employment - Willamette Urology
Stock and Other Ownership Interests - Convergent Genomics
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; BMS; Merck; Pfizer
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck
 
Francisco G. La Rosa
No Relationships to Disclose
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Roche
 
Adam S. Kibel
Honoraria - Blue Earth Diagnostics; Janssen; Merck; profound; Roche
Consulting or Advisory Role - Advantagene; Bristol-Myers Squibb; Candel Therapeutics; Cellvax
Research Funding - Pfizer
 
Daniel Canter
Employment - Roche/Genentech
Speakers' Bureau - Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences
 
Ian M Thompson
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme